Login / Signup

Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.

Rong HeJonathan ChiouAllison ChiouDong ChenConstance P ChenCaroline SpethmanKurt R BessonenJennifer L OliveiraPhuong L NguyenKaaren K ReichardJames D HoyerSimon D AlthoffDana J RohMechelle A MillerJi YuanHoratiu OlteanuKebede H BegnaAyalew TefferiHassan B AlkhateebMirinal S PatnaikMark R LitzowAref A Al-KaliDavid S Viswanatha
Published in: Blood cancer journal (2022)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • patient reported outcomes
  • single molecule
  • patient reported